Astellas Ramps up M&A, Buys U.S. Biotech Xyphos for as Much as $665M

Astellas Pharma Inc (4503.T) has bought U.S.-based Xyphos Biosciences Inc to expand its immuno-oncology business, a deal worth up to $665 million including potential development milestones and its second acquisition announced this month. Japan’s second biggest drugmaker by sales paid $120 million upfront for Xyphos and the rest will be milestone payments, the companies said […]

Astellas Ramps up M&A, Buys U.S. Biotech Xyphos for as Much as $665M Read More »

Fundamental Advisors Announces Sale of The Clare at Rush and Pearson to LCS

Fundamental Advisors LP (“Fundamental”), a leading alternative asset manager focused on municipal, public purpose and community assets, announced the sale of The Clare at Rush and Pearson (“The Clare”), the premier senior housing community in Chicago, to LCS, the nation’s second-largest operator of senior living communities. Terms of the transaction were not disclosed. Read the

Fundamental Advisors Announces Sale of The Clare at Rush and Pearson to LCS Read More »

Frontier Management Announces Acquisition of the Reserve at Towne Lake (Formerly Autumn Leaves)

Frontier Management has announced the acquisition of the management of The Reserve at Towne Lake (Formerly Autumn Leaves at Towne Lake) which is a dedicated forty-eight unit memory care community located off Eagle Drive and Rose Creek Drive. Frontier Management was excited for the opportunity to take over management of The Reserve due to Frontier’s

Frontier Management Announces Acquisition of the Reserve at Towne Lake (Formerly Autumn Leaves) Read More »

Veristat Strengthens Its European Presence with the Acquisition of The Clinical Trial Company Ltd.

Veristat, a full-service CRO, announced today that it has completed the acquisition of The Clinical Trial Company Ltd. (TCTC Group), a global Contract Research Organization headquartered in Europe. TCTC Group provides clinical operations, regulatory, personnel and medical services for full-service clinical studies and stand-alone clinical trials for biopharmaceutical companies throughout the world. Read the full

Veristat Strengthens Its European Presence with the Acquisition of The Clinical Trial Company Ltd. Read More »

Natus Medical Finalizes Transition of Peloton Business to Pediatrix Medical Group

Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced that effective December 31, 2019 the Company has finalized and executed the previously announced transition of the Peloton hearing screening services

Natus Medical Finalizes Transition of Peloton Business to Pediatrix Medical Group Read More »

NOVO Health Services and Paris Healthcare Linen Services to Merge

Peter Farrell, Managing Partner of Tuckahoe Holdings, and David J. Stern, owner, president and CEO of Paris Companies, announce the merger of their subsidiary companies, NOVO Health Services and Paris Healthcare Linen Services, effective January 1, 2020. The merged company will continue doing business as NOVO Health Services, and the Paris trade name will continue

NOVO Health Services and Paris Healthcare Linen Services to Merge Read More »

Tower Health Adds 110 Drexel Medicine Clinicians, Support Staff

The transition of 110 clinicians and staff from Drexel Medicine, Drexel University’s academic medical group, to Tower Health Medical Group became official Jan. 1. Last May, West Reading-based Tower Health and Drexel University in Philadelphia signed a letter of intent to form a combined academic medicine physician practice through Tower Health Medical Group. The group

Tower Health Adds 110 Drexel Medicine Clinicians, Support Staff Read More »

424 Capital Announces Investment in Practis

424 Capital, a lower-middle market growth capital partner, announced that it has completed an investment in Practis, a digital marketing and SaaS software solutions company catering to independent healthcare providers. Together with Eagle Private Capital and Plexus Capital, 424 Capital purchased a majority share from Founder Elizabeth Pettrone and CEO John Pettrone Jr., who will

424 Capital Announces Investment in Practis Read More »

Scroll to Top